Newsbenzinga
Boston Scientific Cuts Forecast on Product Slowdown and Competition
· Published
Article summary
Boston Scientific beat second-quarter estimates but lowered its 2026 sales and earnings outlook as restructuring costs weighed on guidance.
An excerpt from the original article.
Comments —
Loading comments…